Unknown

Dataset Information

0

ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer.


ABSTRACT: Most colorectal (CRC) tumors are dependent on EGFR/KRAS/BRAF/MAPK signaling activation. ARID1A is an epigenetic regulator mutated in approximately 5% of non-hypermutated CRC tumors. Here we show that anti-EGFR but not anti-VEGF treatment enriches for emerging ARID1A mutations in CRC patients. In addition, we find that patients with ARID1A mutations, at baseline, are associated with worse outcome when treated with cetuximab- but not bevacizumab-containing therapies; thus, this suggests that ARID1A mutations may provide both an acquired and intrinsic mechanism of resistance to anti-EGFR therapies. We find that, ARID1A and EGFR-pathway genetic alterations are mutually exclusive across lung and colorectal cancers, further supporting a functional connection between these pathways. Our results not only suggest that ARID1A could be potentially used as a predictive biomarker for cetuximab treatment decisions but also provide a rationale for exploring therapeutic MAPK inhibition in an unexpected but genetically defined segment of CRC patients.

SUBMITTER: Johnson RM 

PROVIDER: S-EPMC9482920 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


Most colorectal (CRC) tumors are dependent on EGFR/KRAS/BRAF/MAPK signaling activation. ARID1A is an epigenetic regulator mutated in approximately 5% of non-hypermutated CRC tumors. Here we show that anti-EGFR but not anti-VEGF treatment enriches for emerging ARID1A mutations in CRC patients. In addition, we find that patients with ARID1A mutations, at baseline, are associated with worse outcome when treated with cetuximab- but not bevacizumab-containing therapies; thus, this suggests that ARID1  ...[more]

Similar Datasets

| S-EPMC6814827 | biostudies-literature
2019-09-21 | E-MTAB-8340 | biostudies-arrayexpress
| S-EPMC5559326 | biostudies-literature
| S-EPMC7508202 | biostudies-literature
| S-EPMC6542644 | biostudies-literature
| S-EPMC6030128 | biostudies-literature
| S-EPMC7381732 | biostudies-literature
| S-EPMC7816326 | biostudies-literature
| PRJEB34338 | ENA
| S-EPMC5008360 | biostudies-literature